Literature DB >> 27692510

Synthesis and Pin1 inhibitory activity of thiazole derivatives.

Hailong Zhao1, Guonan Cui1, Jing Jin1, Xiaoguang Chen2, Bailing Xu3.   

Abstract

Pin1 (Protein interacting with NIMA1) is a peptidyl prolyl cis-trans isomerase (PPIase) which specifically catalyze the conformational conversion of the amide bond of pSer/Thr-Pro motifs in its substrate proteins and is a novel promising anticancer target. A series of new thiazole derivatives were designed and synthesized, and their inhibitory activities were measured against human Pin1 using a protease-coupled enzyme assay. Of all the tested compounds, a number of thiazole derivatives bearing an oxalic acid group at 4-position were found to be potent Pin1 inhibitors with IC50 values at low micromolar level. The detailed structure-activity relationships were analyzed and the binding features of compound 10b (IC50 5.38μM) was predicted using CDOCKER program. The results of this research would provide informative guidance for further optimizing thiazole derivatives as potent Pin1 inhibitors.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Anti-cancer agents; PPIase; Pin1; Pin1 inhibitor; Thiazole derivatives

Mesh:

Substances:

Year:  2016        PMID: 27692510     DOI: 10.1016/j.bmc.2016.09.049

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

Review 1.  Gears-In-Motion: The Interplay of WW and PPIase Domains in Pin1.

Authors:  Yew Mun Lee; Yih-Cherng Liou
Journal:  Front Oncol       Date:  2018-10-25       Impact factor: 6.244

Review 2.  Prolyl isomerase Pin1: a promoter of cancer and a target for therapy.

Authors:  Yang Chen; Ya-Ran Wu; Hong-Ying Yang; Xin-Zhe Li; Meng-Meng Jie; Chang-Jiang Hu; Yu-Yun Wu; Shi-Ming Yang; Ying-Bin Yang
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

3.  A Guide to PIN1 Function and Mutations Across Cancers.

Authors:  Maguie El Boustani; Lucia De Stefano; Isabella Caligiuri; Nayla Mouawad; Carlotta Granchi; Vincenzo Canzonieri; Tiziano Tuccinardi; Antonio Giordano; Flavio Rizzolio
Journal:  Front Pharmacol       Date:  2019-01-22       Impact factor: 5.810

4.  Quantitative Evaluation of in Vivo Target Efficacy of Anti-tumor Agents via an Immunofluorescence and EdU Labeling Strategy.

Authors:  Yujun He; Jin Wen; Qinghua Cui; Fangfang Lai; Dali Yin; Huaqing Cui
Journal:  Front Pharmacol       Date:  2018-07-25       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.